BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

  Financing led by Forbion, with Longitude Capital and founding investors, Novartis Venture Fund and Fountain Healthcare Partners, also participating

  November 19, 2018

   · 

  5 min read
• Business

  InDex Pharmaceuticals Holding AB (publ) Interim Report January - September 2018

  Directed share issue strengthens the cash position ahead of the CONDUCT results

  November 19, 2018

   · 

  4 min read
• Forbion Leads €40m Series B Financing in Inflazome to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

  Funding to advance clinical trials of Inflazome’s pioneering orally-available NLRP3 inflammasome inhibitor compounds in several chronic inflammatory diseases

  November 19, 2018

   · 

  4 min read
• Business

  Sobi™ Appoints Paula Treutiger as Head of Communications and Investor Relations

  Swedish Orphan Biovitrum AB has appointed Paula Treutiger as Head of Communications and Investor Relations. Paula will join Sobi on 1 January 2019 and be part of Sobi’s Executive Committee.

  November 19, 2018

   · 

  2 min read
• Business

  Petco and Express Scripts Team Up to Revolutionize Home Delivery of Pet Medicines

  Pet specialty retailer supports commitment to total pet care and wellness with convenient, accessible pet prescriptions available online for doorstep delivery

  November 19, 2018

   · 

  3 min read
• Job Trends

  New Holiday Cookbook Addresses Diet and Nutrition Needs of Those with Kidney Disease

  DaVita Kidney Care releases ‘Holiday Gatherings’ Cookbook

  November 19, 2018

   · 

  3 min read
• Business

  BiondVax Issues Clarification Regarding Third Quarter 2018 Financial Results

  BiondVax is a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate.

  November 19, 2018

   · 

  3 min read
• Business

  RTI Surgical® Announces HealthPartners’® Positive Coverage Decision for Minimally Invasive Sacroiliac Joint Fusion Surgery

  Decision may help more patients access RTI’s SImmetry® Sacroiliac Joint Fusion System, a minimally invasive surgical solution for sacroiliac (SI) joint dysfunction

  November 19, 2018

   · 

  5 min read